MCKESSON CORP
Close on Oct 19, 2026
- Market cap
- $120.44B
- P/E (TTM)
- 27.1
- Dividend yield
- 0.31%
Earnings
Next report expected Nov 4, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2027 Ended Jun 30, 2026 | Aug 5, 2026 | After market close | $105.40B | $5.15 | $9.93 |
| Q4 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $96.30B | $13.71 | $11.69 |
| Q3 FY2026 Ended Dec 31, 2025 | Feb 4, 2026 | After market close | $106.20B | $9.59 | $9.34 |
| Q2 FY2026 Ended Sep 30, 2025 | Nov 5, 2025 | After market close | $103.20B | $8.92 | $9.86 |
| Q1 FY2026 Ended Jun 30, 2025 | Aug 6, 2025 | After market close | $97.80B | $6.25 | $8.26 |
| Q4 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $90.80B | $10.01 | $10.12 |
| Q3 FY2025 Ended Dec 31, 2024 | Feb 5, 2025 | After market close | $95.30B | $6.95 | $8.03 |
| Q2 FY2025 Ended Sep 30, 2024 | Nov 6, 2024 | After market close | $93.70B | $1.87 | $7.07 |
| Q1 FY2025 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q4 FY2024 Ended Mar 31, 2024 | May 7, 2024 | After market close | – | – | – |
| Q3 FY2024 Ended Dec 31, 2023 | Feb 7, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted Earnings per Diluted Sharenon-GAAP | Fiscal 2027 | 13% to 15% growth | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Mckesson filed with the SEC
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
Regulation FD disclosure · EX-99.1 to Form 8-K
McKESSON REPORTS FISCAL 2027 FIRST QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKESSON REPORTS FISCAL 2026 FOURTH QUARTER AND FULL YEAR RESULTS, PROVIDES FISCAL 2027 GUIDANCE,
Results of operations · EX-99.1 to Form 8-K
MCKESSON CORPORATION ANNOUNCES FOURTH QUARTER FISCAL 2026 EARNINGS RELEASE DATE AND PARTICIPATION IN UPCOMING CONFERENCES
Regulation FD disclosure · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2026 THIRD QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2026 SECOND QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
MCKESSON CORPORATION HIGHLIGHTS STRATEGIC GROWTH STRATEGIES AND UNVEILS UPDATED LONG-TERM FINANCIAL TARGETS AT INVESTOR DAY
Regulation FD disclosure · EX-99.1 to Form 8-K
SUPPLEMENTAL HISTORICAL SEGMENT FINANCIAL INFORMATION
Results of operations · Other events · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2026 FIRST QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
New York, New York 10019
New financial obligation · Other events · EX-99.1 to Form 8-K
McKESSON REPORTS FISCAL 2025 FOURTH QUARTER AND FULL YEAR RESULTS
Results of operations · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2025 THIRD QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K/A
McKESSON CORPORATION REPORTS FISCAL 2025 THIRD QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2025 SECOND QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
New York, New York 10013
New financial obligation · Other events · EX-99.1 to Form 8-K
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2025 FIRST QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKesson’s Board of Directors Elects Deborah Dunsire as New Director
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2024 FOURTH QUARTER
Results of operations · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2024 THIRD QUARTER RESULTS AND RAISES FULL YEAR GUIDANCE
Results of operations · EX-99.1 to Form 8-K
MCKESSON TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2024 SECOND QUARTER RESULTS AND RAISES FULL YEAR GUIDANCE
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2024 FIRST QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
New York, New York 10036
Agreement terminated · New financial obligation · Other events · EX-99.1 to Form 8-K
McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024
Other events · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2023 FOURTH-QUARTER
Results of operations · EX-99.1 to Form 8-K
of the several Underwriters named in Schedule I hereto
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2023 THIRD-QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKESSON CORPORATION REPORTS FISCAL 2023 SECOND-QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
8-K EARNINGS RELEASE 6.30.2022 1Q23
Results of operations · EX-99.1 to Form 8-K
McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS
Results of operations · EX-99.1 to Form 8-K
McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
List of states and territories that have agreed to the opioids-related Settlement:
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Distributors Approve Opioid Settlement Agreement
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
McKESSON REPORTS FISCAL 2022 THIRD-QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K